Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avinger IncAVGR · Entity 83897 | Chief Financial Officer | March 01, 2018 | March 05, 2018 |
| ELUTIA INC.ELUT · Entity 7342 | CHIEF FINANCIAL OFFICER | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avinger Inc
Report date March 01, 2018 · Filed March 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 850 |
Reported balance
After 2018-03-01 transaction · row 1
1 source rowRow 1 · 2018-03-01 · Other · Acquired 62 · Balance 850 F1: The reporting person is a participant of the 2015 Employee Stock Purchase Plan, which made a purchase for $0.9265 per share consideration of Common Stock of the Issuer on March 1, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is a participant of the 2015 Employee Stock Purchase Plan, which made a purchase for $0.9265 per share consideration of Common Stock of the Issuer on March 1, 2018.
ELUTIA INC.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 489,903 |
Last balance in matching sequence
After 2026-09-10 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-09-10 · Exercise / conversion · Acquired 12,500 · Balance 494,389 F1: Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: Includes 1,807 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. Row 2 · 2026-09-10 · Tax withholding · Disposed 4,486 · Balance 489,903 F4: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units. F3: Includes 1,807 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,500 |
Reported balance
After 2026-09-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-10 · Exercise / conversion · Disposed 12,500 · Balance 12,500 F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5: On January 31, 2024, the Reporting Person was granted 150,000 restricted stock units, Restricted stock units as to 1/6 vest on June 10, 2024, and as to 1/12 vest quarterly on each of the following dates: September 10, 2024, December 10, 2024, March 10, 2025, June 10, 2025, September 10, 2025, December 10, 2025, March 10, 2026, June 10, 2026, September 10, 2026, and December 10, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F3: Includes 1,807 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
F4: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F5: On January 31, 2024, the Reporting Person was granted 150,000 restricted stock units, Restricted stock units as to 1/6 vest on June 10, 2024, and as to 1/12 vest quarterly on each of the following dates: September 10, 2024, December 10, 2024, March 10, 2025, June 10, 2025, September 10, 2025, December 10, 2025, March 10, 2026, June 10, 2026, September 10, 2026, and December 10, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2024 Filed Feb 2, 2024 16:35 UTC | ELUTIA INC. ELUT · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001415889-24-002305 · form4-02022024_090206.xml · derivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Class A Common Stock · 150,000 shares Expires 2034-01-31 F1 · derivative.exercise_date: The option vests monthly over three years beginning one month after grant date such that the option shall be fully vested and exercisable on January 31, 2027. Read SEC document |
| September 21, 2023 Filed Sep 21, 2023 16:50 UTC | ELUTIA INC. ELUT · Entity 7342 | GrantWarrants (rights to buy) · Derivative | 105,080 | Not disclosed Strike: $1.43 | Not disclosed |
DisclosureSEC source: 0001415889-23-013473 · form4-09212023_080929.xml · derivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,080 Underlying: Class A Common Stock · 105,080 shares Expires not disclosed F1 · price: The reported securities are included within the 70,053 Units purchased by the reporting person for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock and one warrant to purchase one and one-half shares of Class A Common Stock. F3 · derivative.expiration_date: The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028. Read SEC document |
| September 21, 2023 Filed Sep 21, 2023 16:50 UTC | ELUTIA INC. ELUT · Entity 7342 | GrantClass A Common Stock | 70,053 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-013473 · form4-09212023_080929.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,519 F1 · price: The reported securities are included within the 70,053 Units purchased by the reporting person for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock and one warrant to purchase one and one-half shares of Class A Common Stock. F2 · balance_after: Includes 901 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:11 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 1,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004624 · form4-03102023_020359.xml · derivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,575 Underlying: Class A Common Stock · 1,287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F2 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022. F2 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:11 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 1,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004624 · form4-03102023_020359.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 20:44 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 2,000 | $3.61 | $7,220.00 |
DisclosureSEC source: 0001415889-22-012089 · form4-12062022_011258.xml · nonDerivative · entry 3 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,217 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.56 to $3.65. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 20:44 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 20,000 | $4.75 | $95,000.00 |
DisclosureSEC source: 0001415889-22-012089 · form4-12062022_011258.xml · nonDerivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,217 Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 20:44 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 6,000 | $4.03 | $24,180.00 |
DisclosureSEC source: 0001415889-22-012089 · form4-12062022_011258.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,217 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.00 to $4.05. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 17:14 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 13,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009542 · form4-09122022_020953.xml · derivative · entry 3 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 13,874 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F4 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. F4 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 17:14 UTC | ELUTIA INC. AZYO · Entity 7342 | Tax withholdingClass A Common Stock | 4,798 | $7.30 | $35,025.40 |
DisclosureSEC source: 0001415889-22-009542 · form4-09122022_020953.xml · nonDerivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,217 F3 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 17:14 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 13,874 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-009542 · form4-09122022_020953.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F2 · balance_after: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:35 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 13,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002860 · form4-03102022_050359.xml · derivative · entry 5 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,874 Underlying: Class A Common Stock · 13,874 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. F7 · derivative.exercise_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. F7 · derivative.expiration_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:35 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002860 · form4-03102022_050359.xml · derivative · entry 4 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,862 Underlying: Class A Common Stock · 1,288 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. F6 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022. F6 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:35 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002860 · form4-03102022_050359.xml · derivative · entry 3 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Class A Common Stock · 8,700 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. F5 · derivative.exercise_date: The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. F5 · derivative.expiration_date: The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:35 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001415889-22-002860 · form4-03102022_050359.xml · derivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Class A Common Stock · 31,000 shares Expires 2032-03-08 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 20:35 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002860 · form4-03102022_050359.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. F2 · balance_after: Includes 4,552 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:01 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 1,000 | $11.00 | $11,000.00 |
DisclosureSEC source: 0001104659-21-065258 · tm2116094-1_4seq1.xml · nonDerivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Read SEC document |
| May 10, 2021 Filed May 12, 2021 18:01 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 1,300 | $11.14 | $14,482.00 |
DisclosureSEC source: 0001104659-21-065258 · tm2116094-1_4seq1.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.97 to $11.21. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | ELUTIA INC. AYZO · Entity 7342 | GrantRESTRICTED STOCK UNITS · Derivative | 5,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-034463 · tm219212-4_4seq1.xml · derivative · entry 2 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,150 Underlying: CLASS A COMMON STOCK · 5,150 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:19 UTC | ELUTIA INC. AYZO · Entity 7342 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 30,900 | $0.00 Strike: $14.53 | $0.00 |
DisclosureSEC source: 0001104659-21-034463 · tm219212-4_4seq1.xml · derivative · entry 1 Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,900 Underlying: CLASS A COMMON STOCK · 30,900 shares Expires 2031-03-08 F1 · derivative.exercise_date: This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 20:27 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 81,800 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113578 · a4.xml · derivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,800 Underlying: Class A Common Stock · 81,800 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 18:10 UTC | Avinger Inc AVGR · Entity 83897 | OtherCommon Stock | 62 | $0.93 | $57.44 |
DisclosureSEC source: 0001593968-18-000491 · primary_01.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 F1 · kind: The reporting person is a participant of the 2015 Employee Stock Purchase Plan, which made a purchase for $0.9265 per share consideration of Common Stock of the Issuer on March 1, 2018. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 21:11 UTC | Avinger Inc AVGR · Entity 83897 | GrantOption (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001593968-17-000457 · primary_01.xml · derivative · entry 2 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,263 Underlying: Common Stock · 50,000 shares Expires 2027-03-13 F3 · derivative.exercise_date: The stock options vest 25% on the first anniversary of the transaction date and monthly thereafter in 36 equal increments. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 21:11 UTC | Avinger Inc AVGR · Entity 83897 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000457 · primary_01.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,927 F1 · price: Reporting person received a grant under the 2015 Equity Incentive Plan of RSUs with a grant date fair market value of $2.05 per share. The RSUs vest annually over four years in equal increments. F2 · balance_after: Includes 34,375 shares of Avinger, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 20:52 UTC | Avinger Inc AVGR · Entity 83897 | OtherCommon Stock | 2,500 | $2.38 | $5,950.00 |
DisclosureSEC source: 0001593968-17-000400 · primary_01.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,427 F1 · kind: The reporting person is a participant of the 2015 Employee Stock Purchase Plan, which made a purchase for $2.38 per share consideration of Common Stock of the Issuer on March 1, 2017. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:26 UTC | Avinger Inc AVGR · Entity 83897 | OtherCommon Stock | 770 | $3.58 | $2,756.60 |
DisclosureSEC source: 0001593968-16-001041 · primary_01.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,524 F1 · kind: The reporting person is a participant of the 2015 Employee Stock Purchase Plan, which made a purchase for $3.58 per share consideration of Common Stock of the Issuer on September 1, 2016. Read SEC document |
| September 01, 2016 Filed Jan 17, 2017 16:04 UTC Amendment | Avinger Inc AVGR · Entity 83897 | OtherCommon Stock | 173 | $3.58 | $619.34 |
DisclosureSEC source: 0001593968-17-000099 · primary_01.xml · nonDerivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,927 F1 · shares: The shares acquired through participation by the reporting person in the 2015 Employee Stock Purchase Plan on September 1, 2016, were incorrectly reported due to a clerical error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.